Tech pairs pharma firms with providers to boost patient connection

AmerisourceBergen has launched Clinical Trial Navigator, a suite of solutions designed to help clinical trials recruit with the help of community-based specialty. Specifically, it unites oncology practices and patients with trial opportunities through advanced site selection, patient identification, and enrolment tools.

Carol Riley, practice administrator with St. Louis Cancer Care, commented, “Clinical trials present the opportunity for patients to access cutting-edge therapies and offer hope for patients who may have exhausted all available treatment options; however, there have been limits to accessing this research for patients at my community-based practice. Programs that enhance and streamline recruitment efforts for community practices are much needed, and having the ability to connect more patients with active trials will be a huge win.”

To find out about Clinical Trial Navigator, Outsourcing-Pharma connected with Jenny Sherak, senior vice president and president of specialty physician services with AmeriSourceBergen.

OSP: Could you please share your perspective on disparities in healthcare, and how attitudes and awareness in the clinical research field have evolved in recent years?


Jenny Sherak, SVP/president of specialty physician services, AmeriSourceBergen

JS: There’s no denying that segments of the U.S. population—based on a range of social, racial and ethnic, environmental, economic, and geographic factors—are disproportionately less likely to receive the recommended standard of care​ for cancer and other complex diseases. In particular, the landmark study published in 2002 by the Institute of Medicine​ served as a wake-up call for the industry, and the onset of the COVID-19 pandemic renewed the urgency to make progress on closing gaps in care sooner rather than later.

Source link

Leave A Reply

Your email address will not be published.